Patricia M. Danzon : Citation Profile

Are you Patricia M. Danzon?

University of Pennsylvania

17

H index

26

i10 index

1197

Citations

RESEARCH PRODUCTION:

42

Articles

17

Papers

3

Books

6

Chapters

EDITOR:

1

Books edited

RESEARCH ACTIVITY:

   36 years (1982 - 2018). See details.
   Cites by year: 33
   Journals where Patricia M. Danzon has often published
   Relations with other researchers
   Recent citing documents: 47.    Total self citations: 20 (1.64 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pda291
   Updated: 2024-12-03    RAS profile: 2024-04-05    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Authors registered in RePEc who have co-authored more than one work in the last five years with Patricia M. Danzon.

Is cited by:

Brekke, Kurt (27)

Straume, Odd Rune (20)

Pammolli, Fabio (17)

Dubois, Pierre (15)

Magazzini, Laura (13)

Grembi, Veronica (13)

Jimenez-Martin, Sergi (13)

Jelovac, Izabela (12)

Cabrales, Antonio (11)

Riccaboni, Massimo (11)

Allain, Marie-Laure (11)

Cites to:

Szymanski, Stefan (8)

Valletti, Tommaso (8)

Cockburn, Iain (8)

DiMasi, Joseph (6)

Jack, William (6)

Dranove, David (6)

Kyle, Margaret (6)

Philipson, Tomas (5)

Henderson, Rebecca (5)

Lerner, Josh (4)

Salkever, David (4)

Main data

Where Patricia M. Danzon has published?

Journals with more than one article published# docs
Journal of Law and Economics5
Journal of Health Economics5
Journal of Policy Analysis and Management4
Health Economics4
International Journal of the Economics of Business3
The Journal of Legal Studies2
American Economic Review2
Managerial and Decision Economics2
The Journal of Business2

Working Papers Series with more than one paper published# docs
NBER Working Papers / National Bureau of Economic Research, Inc10
Monograph / Office of Health Economics3
Working Papers / The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State2

Recent works citing Patricia M. Danzon (2024 and 2023)

YearTitle of citing document
2024.

Full description at Econpapers || Download paper

2023Who pays for gifts to physicians? Heterogeneous effects of industry payments on drug costs. (2022). Newham, Melissa ; Valente, Marica. In: Papers. RePEc:arx:papers:2203.01778.

Full description at Econpapers || Download paper

2024The Impact of Acquisitions on Inventors Turnover in the Biotechnology Industry. (2022). Riccaboni, Massimo ; van Lidth, Jeroen ; Parisi, Federica ; Verginer, Luca. In: Papers. RePEc:arx:papers:2203.12968.

Full description at Econpapers || Download paper

2023Exploring the Dynamics of the Specialty Insurance Market Using a Novel Discrete Event Simulation Framework: a Lloyds of London Case Study. (2023). Tua, Alan ; Feng, Zhe ; Kam, Keith ; Ahmed, Akhil ; Olmez, Sedar. In: Papers. RePEc:arx:papers:2307.05581.

Full description at Econpapers || Download paper

2023Medical Malpractice and Contract Disclosure: An Equilibrium Model of the Effects of Legal Rules on Behavior in Health Care Markets. (0000). Zeiler, Kathryn. In: American Law & Economics Association Annual Meetings. RePEc:bep:alecam:1071.

Full description at Econpapers || Download paper

2024Nonlinear Cointegration Relationships Between Non-Life Insurance Premiums and Financial Markets. (2009). Sghaier, Nadia ; JAWADI, Fredj ; Bruneau, Catherine. In: Journal of Risk & Insurance. RePEc:bla:jrinsu:v:76:y:2009:i:3:p:753-783.

Full description at Econpapers || Download paper

2023The impact of monitor choice on insurer loss reserves. (2023). Sirmans, Eleanor Tice ; Montesinos, Hugo Moises ; McCullough, Kathleen ; Bisco, Jill. In: Risk Management and Insurance Review. RePEc:bla:rmgtin:v:26:y:2023:i:1:p:83-105.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

2023The Right to Health and the Health Effects of Denials. (2023). Fernndez, Manuel ; Bhalotra, Sonia. In: CAGE Online Working Paper Series. RePEc:cge:wacage:660.

Full description at Econpapers || Download paper

2023A cost-benefit analysis of the medicines patent pool. (2023). Wang, Lucy Xiaolu. In: Economics Bulletin. RePEc:ebl:ecbull:eb-23-00047.

Full description at Econpapers || Download paper

2024Health policy, price regulation, and innovation: Evidence from China’s vaccine industry. (2024). Shi, Ce Matthew ; Geng, Hao. In: Journal of Development Economics. RePEc:eee:deveco:v:167:y:2024:i:c:s0304387823001852.

Full description at Econpapers || Download paper

2023Contingent factors of the coinsurance function of internal capital markets: Evidence from the US nonlife insurance industry. (2023). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: The North American Journal of Economics and Finance. RePEc:eee:ecofin:v:66:y:2023:i:c:s1062940823000311.

Full description at Econpapers || Download paper

2023Risk-sharing function in internal capital markets: Evidence from intragroup reinsurance activities. (2023). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: International Review of Financial Analysis. RePEc:eee:finana:v:87:y:2023:i:c:s1057521923001503.

Full description at Econpapers || Download paper

2023Are blockchain and cryptocurrency M&As harder to close?. (2023). Simsir, Serif Aziz ; Akdou, Evrim. In: Finance Research Letters. RePEc:eee:finlet:v:52:y:2023:i:c:s1544612322006766.

Full description at Econpapers || Download paper

2024The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis. (2024). Hollis, Aidan ; Grootendorst, Paul ; Guh, Daphne P ; Zhang, Wei ; Anis, Aslam H. In: Health Policy. RePEc:eee:hepoli:v:144:y:2024:i:c:s0168851024000745.

Full description at Econpapers || Download paper

2023Market for artificial intelligence in health care and compensation for medical errors. (2023). Musy, Olivier ; CHOPARD, Bertrand. In: International Review of Law and Economics. RePEc:eee:irlaec:v:75:y:2023:i:c:s0144818823000315.

Full description at Econpapers || Download paper

2024Market discipline and policy loans. (2024). Niehaus, Greg ; Chiang, Chia-Chun. In: Journal of Banking & Finance. RePEc:eee:jbfina:v:159:y:2024:i:c:s0378426623002716.

Full description at Econpapers || Download paper

2023The functions of known to be inaccurate prices in markets: A cross-country comparison of pharmaceutical list pricing. (2023). Krafve, Linus Johansson ; Sjogren, Ebba ; Kjellberg, Hans. In: Journal of Business Research. RePEc:eee:jbrese:v:167:y:2023:i:c:s0148296323005520.

Full description at Econpapers || Download paper

2024The interplay between product development failures and alliance portfolio properties in the formation of exploration versus exploitation alliances. (2024). Ozmel, Umit ; Bae, Joonhyung. In: Journal of Business Research. RePEc:eee:jbrese:v:177:y:2024:i:c:s0148296324001267.

Full description at Econpapers || Download paper

2023The short- and long-run effects of medical malpractice lawsuits on medical spending and hospital operations in China. (2023). Yi, Junjian ; Liu, Gordon ; Zhao, Shaoyang ; Yuan, YE. In: Journal of Comparative Economics. RePEc:eee:jcecon:v:51:y:2023:i:4:p:1142-1161.

Full description at Econpapers || Download paper

2023Negative network effects and public policy in vaccine markets. (2023). Tian, Jingwen ; Liu, Zhiwei ; Amir, Rabah. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:216:y:2023:i:c:p:136-149.

Full description at Econpapers || Download paper

2023Financing the litigation arms race. (2023). Grenadier, Steven R ; Antill, Samuel. In: Journal of Financial Economics. RePEc:eee:jfinec:v:149:y:2023:i:2:p:218-234.

Full description at Econpapers || Download paper

2023The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets. (2023). Straume, Odd Rune ; Dalen, Dag Morten ; Brekke, Kurt R. In: Journal of Health Economics. RePEc:eee:jhecon:v:90:y:2023:i:c:s0167629623000553.

Full description at Econpapers || Download paper

2023The effect of RCTs on drug demand: Evidence from off-label cancer drugs. (2023). McKibbin, Rebecca. In: Journal of Health Economics. RePEc:eee:jhecon:v:90:y:2023:i:c:s0167629623000565.

Full description at Econpapers || Download paper

2023Patent term extensions and commercialization lags in the pharmaceutical industry: A growth-theoretic analysis. (2023). Lu, You-Xun ; Hu, Mei-Ying ; Lai, Ching-Chong. In: Journal of Macroeconomics. RePEc:eee:jmacro:v:76:y:2023:i:c:s0164070423000198.

Full description at Econpapers || Download paper

2023The heterogeneous impacts of M&As on renewable energy firms’ innovation: Comparative analysis of China, the US and EU. (2023). Lv, Xin ; Dong, Weijia ; Qiao, LU. In: International Review of Economics & Finance. RePEc:eee:reveco:v:87:y:2023:i:c:p:306-323.

Full description at Econpapers || Download paper

2024Internal versus external capital markets and risk-taking. (2024). Shiu, Yung-Ming ; Hsiao, Ching-Yuan. In: International Review of Economics & Finance. RePEc:eee:reveco:v:92:y:2024:i:c:p:503-519.

Full description at Econpapers || Download paper

2023The role of patient organisations in research and development: Evidence from rare diseases. (2023). Miraldo, Marisa ; Gentilini, Arianna. In: Social Science & Medicine. RePEc:eee:socmed:v:338:y:2023:i:c:s0277953623006895.

Full description at Econpapers || Download paper

2023The role of government-industry-academia partnership in business incubation: Evidence from new R&D institutions in China. (2023). Wang, Mingyue ; Zhou, Junbi. In: Technology in Society. RePEc:eee:teinso:v:72:y:2023:i:c:s0160791x22003359.

Full description at Econpapers || Download paper

2023The Effects of Price Regulation on Pharmaceutical Expenditure and Availability. (2023). Toivanen, Otto ; Siikanen, Markku ; Markkanen, Jaakko ; Kortelainen, Mika. In: Working Papers. RePEc:fer:wpaper:157.

Full description at Econpapers || Download paper

2023Underwriting Cycles in Property-Casualty Insurance: The Impact of Catastrophic Events. (2023). Sattarhoff, Cristina ; Hofmann, Annette. In: Risks. RePEc:gam:jrisks:v:11:y:2023:i:4:p:75-:d:1121004.

Full description at Econpapers || Download paper

2023What do we know about startup-valuation drivers? A systematic literature review 1. (2023). le Pendeven, Benjamin ; Berre, Max. In: Post-Print. RePEc:hal:journl:hal-04232855.

Full description at Econpapers || Download paper

2023Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis. (2023). Cipriano, Lauren E ; Goldhaber-Fiebert, Jeremy D. In: Medical Decision Making. RePEc:sae:medema:v:43:y:2023:i:7-8:p:914-929.

Full description at Econpapers || Download paper

2023Does health technology assessment compromise access to pharmaceuticals?. (2023). Stargardt, Tom ; Bussgen, Melanie. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:24:y:2023:i:3:d:10.1007_s10198-022-01484-4.

Full description at Econpapers || Download paper

2023Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier Effects. (2023). Exel, Job ; Hoefman, Renske ; Verbooy, Kaya ; Brouwer, Werner. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01253-y.

Full description at Econpapers || Download paper

2023Measuring the Indirect Cost of Illness Using EQ-5D-5L While Accounting for Job Characteristics. (2023). Jakubczyk, Micha ; Ko, Beata. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01267-6.

Full description at Econpapers || Download paper

2023Multiplier Effects and Compensation Mechanisms for Inclusion in Health Economic Evaluation: A Systematic Review. (2023). Roijen, Leona Hakkaart ; Brouwer, Werner ; Hosseinnia, Nikkie ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:9:d:10.1007_s40273-023-01304-4.

Full description at Econpapers || Download paper

2023Pharmaceutical regulation under market integration through parallel trade. (2023). Birg, Laura. In: Canadian Journal of Economics/Revue canadienne d'économique. RePEc:wly:canjec:v:56:y:2023:i:4:p:1322-1346.

Full description at Econpapers || Download paper

2023Parallel imports under a manufacturer rebate and a price freeze: Evidence from Germany. (2023). Birg, Laura. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:2:p:302-323.

Full description at Econpapers || Download paper

2023Partially different? The importance of general equilibrium in health economic evaluations: An application to nocturia. (2023). Yerushalmi, Erez ; Burtea, Teodor ; Andersson, Fredrik L ; Hafner, Marco. In: Health Economics. RePEc:wly:hlthec:v:32:y:2023:i:3:p:654-674.

Full description at Econpapers || Download paper

2023.

Full description at Econpapers || Download paper

Patricia M. Danzon has edited the books:

YearTitleTypeCited

Works by Patricia M. Danzon:

YearTitleTypeCited
1988The Political Economy of Workers Compensation: Lessons for Product Liability. In: American Economic Review.
[Full Text][Citation analysis]		article2
1990The Effects of Malpractice Litigation on Physicians Fees and Incomes. In: American Economic Review.
[Full Text][Citation analysis]		article7
.() In: .
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 7		paper
1991Liability for Medical Malpractice In: Journal of Economic Perspectives.
[Full Text][Citation analysis]		article81
2000Liability for medical malpractice.(2000) In: Handbook of Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 81		chapter
1994Health Care Reform In: Australian Economic Review.
[Full Text][Citation analysis]		article8
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand In: Forum for Health Economics & Policy.
[Full Text][Citation analysis]		article62
2004Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand.(2004) In: NBER Chapters.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 62		chapter
2003Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 62		paper
1994The Swedish patient compensation system: Myths and realities In: International Review of Law and Economics.
[Full Text][Citation analysis]		article3
2008Crises in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market In: Journal of Banking & Finance.
[Full Text][Citation analysis]		article10
1997Price, Financial Quality, and Capital Flows in Insurance Markets In: Journal of Financial Intermediation.
[Full Text][Citation analysis]		article104
2000Cross-national price differences for pharmaceuticals: how large, and why? In: Journal of Health Economics.
[Full Text][Citation analysis]		article94
1982Hospital `profits : The effects of reimbursement policies In: Journal of Health Economics.
[Full Text][Citation analysis]		article16
2002Welfare effects of supplementary insurance: a comment In: Journal of Health Economics.
[Full Text][Citation analysis]		article10
2005Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances In: Journal of Health Economics.
[Full Text][Citation analysis]		article84
2003Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances.(2003) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 84		paper
1985Liability and liability insurance for medical malpractice In: Journal of Health Economics.
[Full Text][Citation analysis]		article21
1984Separation of the redistributive and allocative functions of government : A public choice perspective In: Journal of Public Economics.
[Full Text][Citation analysis]		article5
2012Regulation of the Biopharmaceutical Industry In: Chapters.
[Full Text][Citation analysis]		chapter0
2012Effects of Regulation on Drug Launch and Pricing in Interdependent Markets In: Advances in Health Economics and Health Services Research.
[Full Text][Citation analysis]		chapter28
2008Effects of Regulation on Drug Launch and Pricing in Interdependent Markets.(2008) In: NBER Working Papers.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 28		paper
1990THE EFFECTS OF MALPRACTICE LITIGATION ON PHYSICIANS FEES AND INCOME. In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]		paper4
1990Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects In: University of Chicago - George G. Stigler Center for Study of Economy and State.
[Citation analysis]		paper2
2002Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy In: Center for Policy Research Policy Briefs.
[Full Text][Citation analysis]		paper0
In: .
[Full Text][Citation analysis]		paper0
2007At what price? In: Nature.
[Full Text][Citation analysis]		article3
2014Regulation of the Pharmaceutical-Biotechnology Industry In: NBER Chapters.
[Full Text][Citation analysis]		chapter4
1999The Effects of Price Regulation on Productivity in Pharmaceuticals In: NBER Chapters.
[Full Text][Citation analysis]		chapter2
2004Mergers and Acquisitions in the Pharmaceutical and Biotech Industries In: NBER Working Papers.
[Full Text][Citation analysis]		paper78
2007Mergers and acquisitions in the pharmaceutical and biotech industries.(2007) In: Managerial and Decision Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 78		article
2011Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement In: NBER Working Papers.
[Full Text][Citation analysis]		paper15
2015Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 15		article
2011Vaccine Supply: Effects Of Regulation And Competition In: NBER Working Papers.
[Full Text][Citation analysis]		paper7
2011Vaccine Supply: Effects of Regulation and Competition.(2011) In: International Journal of the Economics of Business.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 7		article
2011Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets In: NBER Working Papers.
[Full Text][Citation analysis]		paper20
2012Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context In: NBER Working Papers.
[Full Text][Citation analysis]		paper17
2015Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has nother version. Agregated cites: 17		article
2002Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality In: NBER Working Papers.
[Full Text][Citation analysis]		paper69
2003The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s In: NBER Working Papers.
[Full Text][Citation analysis]		paper8
1997Trade and Price Differentials for Pharmaceuticals: Policy Options In: Monograph.
[Full Text][Citation analysis]		book5
2000Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison In: Monograph.
[Full Text][Citation analysis]		book4
2002The Life Cycle of Pharmaceuticals: A Cross-National Perspective In: Monograph.
[Full Text][Citation analysis]		book6
2011Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? In: Occasional Paper.
[Full Text][Citation analysis]		paper2
1994Tort Reform: The Case of Medical Malpractice. In: Oxford Review of Economic Policy.
[Citation analysis]		article1
1990Alternative Liability Regimes for Medical Injuries In: The Geneva Papers on Risk and Insurance - Issues and Practice.
[Full Text][Citation analysis]		article4
1983Contingent Fees for Personal Injury Litigation In: Bell Journal of Economics.
[Full Text][Citation analysis]		article53
2018Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues In: PharmacoEconomics.
[Full Text][Citation analysis]		article13
2015Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? In: International Journal of the Economics of Business.
[Full Text][Citation analysis]		article0
1997Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU In: International Journal of the Economics of Business.
[Full Text][Citation analysis]		article33
1993The Economic Implications of Public Disability Insurance in the United States. In: Journal of Labor Economics.
[Full Text][Citation analysis]		article13
2002Health Insurance and the Growth in Pharmaceutical Expenditures In: Journal of Law and Economics.
[Full Text][Citation analysis]		article19
1984The Frequency and Severity of Medical Malpractice Claims. In: Journal of Law and Economics.
[Full Text][Citation analysis]		article36
1993Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment. In: Journal of Law and Economics.
[Full Text][Citation analysis]		article0
2000Does Regulation Drive out Competition in Pharmaceutical Markets? In: Journal of Law and Economics.
[Full Text][Citation analysis]		article106
2001Workers Compensation Rate Regulation: How Price Controls Increase Costs. In: Journal of Law and Economics.
[Full Text][Citation analysis]		article11
1997Tort Liability: A Minefield for Managed Care? In: The Journal of Legal Studies.
[Full Text][Citation analysis]		article17
2001Comments on The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions. In: The Journal of Legal Studies.
[Full Text][Citation analysis]		article0
1994Price Cutting in Liability Insurance Markets. In: The Journal of Business.
[Full Text][Citation analysis]		article30
2000Rate Regulation, Safety Incentives, and Loss Growth in Workers Compensation Insurance. In: The Journal of Business.
[Full Text][Citation analysis]		article6
2002A general model of the impact of absenteeism on employers and employees In: Health Economics.
[Full Text][Citation analysis]		article42
1999Medical negligence and the NHS: an economic analysis In: Health Economics.
[Full Text][Citation analysis]		article8
1995A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]		article0
1982Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]		article0
1983Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]		article0
1983Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 In: Journal of Policy Analysis and Management.
[Full Text][Citation analysis]		article1
2007Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion In: Managerial and Decision Economics.
[Full Text][Citation analysis]		article6
In: .
[Full Text][Citation analysis]		paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Last updated November, 3 2024. Contact: CitEc Team